Better Context Better Decisions

Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.

news cover image
$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, Other, SGLT2i Sep 13 | 2021September 13-16 CHMP Agenda; Dexcom Exec Joins iRhythm as CEO; Provention Teplizumab UpdatePurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin Aug 26 | 2021Lannett CY Q2 ‘21 (FY Q4 '21) Earnings UpdatePurchase Blast
$599
Posted in: Glucagon, Glucose Monitoring, Insulin Delivery Aug 24 | 2021Gvoke Kit Receives FDA Approval; Medtronic Q2 '21 Earnings UpdatePurchase Blast
news cover image
$599
Posted in: Glucagon, Other, SGLT2i Aug 23 | 2021Lexicon and Amarin Present Data at ESC 2021Purchase Blast
BI and lilly cover image
$599
Posted in: SGLT2i Aug 23 | 2021EMPEROR-Reduced Label AnalysisPurchase Blast
1 2 3 59

Get the Latest Analysis

Stay informed and aligned with frequent updates to keep a pulse on the industry.

If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.